CNLCX
Price
$9.51
Change
-$0.04 (-0.42%)
Updated
Jun 5 closing price
Net Assets
13.13B
RILAX
Price
$9.34
Change
-$0.05 (-0.53%)
Updated
Jun 5 closing price
Net Assets
13.13B
Interact to see
Advertisement

CNLCX vs RILAX

Header iconCNLCX vs RILAX Comparison
Open Charts CNLCX vs RILAXBanner chart's image
CNLCX vs RILAX Comparison Chart in %
View a ticker or compare two or three
VS
CNLCX vs. RILAX commentary
Jun 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNLCX is a Hold and RILAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNLCX (13.1B) and RILAX (13.1B) have equal amount of cash in the bank . RILAX pays higher dividends than CNLCX: RILAX (2.71) vs CNLCX (2.34). CNLCX was incepted earlier than RILAX: CNLCX (11 years) vs RILAX (11 years). CNLCX (1.44) and RILAX (1.40) have similar cost to investors . CNLCX (12.00) and RILAX (12.00) have comparable annual turnover. CNLCX (250) and RILAX (250) have matching initial minimum investment requirements. RILAX annual gain was more profitable for investors over the last year : 3.84 vs. CNLCX (3.56). RILAX return over 5 years is better than : -2.12 vs. CNLCX (-2.40).
CNLCXRILAXCNLCX / RILAX
Total Expense Ratio1.441.40103%
Annual Report Gross Expense Ratio1.441.40103%
Fund Existence11 years11 years-
Gain YTD0.9511.07688%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets13.1B13.1B100%
Annual Yield % from dividends2.342.7187%
Returns for 1 year3.563.8493%
Returns for 3 years8.178.5596%
Returns for 5 years-2.40-2.12113%
Returns for 10 years14.0714.3898%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERCX65.23N/A
N/A
American Funds EUPAC R3
PHSZX46.53N/A
N/A
PGIM Jennison Health Sciences Z
WSBFX24.32N/A
N/A
Boston Trust Walden Balanced
JWWCX126.25N/A
N/A
Janus Henderson Global Research C
MATFX27.36N/A
N/A
Matthews Asia Innovators Investor